A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
The Institute of Molecular and Translational Medicine, Czech Republic
Olympion Medical Center
Washington University School of Medicine
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
University of Utah
HonorHealth Research Institute
University of Utah
First People's Hospital of Hangzhou
University of Ulm
Duke University
Sahlgrenska University Hospital
Sahlgrenska University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, Irvine
University of Utah